Literature DB >> 6307552

Plasma immunoreactive beta-endorphin is elevated in uraemia.

N Aronin, D T Krieger.   

Abstract

Plasma immunoreactive-(IR) beta-endorphin (beta-EP) and beta-lipotrophin (beta-LPH) levels were measured in 15 adult uraemic patients on chronic haemodialysis. The presence of immunoreactivity eluting in the position of beta-EP was demonstrated following submission of pooled extracts of uraemic plasma to gel permeation chromatography on Sephadex G-50. To separate beta-EP from beta-LPH, pre-dialysis plasma extracts from six individual patients, and three pools of three patients each, were submitted to sequential immune-affinity chromatography and levels were measured by radioimmunoassay. In all cases, plasma IR beta-EP concentrations were markedly increased compared with normal subjects (m +/- SEM fmol/ml; 64.4 +/- 13.7 vs. 2.3 +/- 0.2). IR beta-LPH concentrations were also increased (m +/- SEM fmol/ml; 55.7 +/- 13.2 vs. normal 6.1 +/- 0.8). In addition, post-dialysis concentrations of plasma IR beta-EP and beta-LPH were lower than pre-dialysis levels (n = 4).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307552     DOI: 10.1111/j.1365-2265.1983.tb02875.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Serum beta-endorphin in non-dialysed and haemodialysed patients with chronic renal failure.

Authors:  P Trelewicz; W Grzeszczak; R Drabczyk
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

Review 2.  Menstrual dysfunction in pathophysiologic states.

Authors:  L S Neinstein
Journal:  West J Med       Date:  1985-10

Review 3.  Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.

Authors:  Raymond Vanholder; Anneleen Pletinck; Eva Schepers; Griet Glorieux
Journal:  Toxins (Basel)       Date:  2018-01-08       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.